| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |